[HTML][HTML] Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience

R Mohd, NE Mohammad Kazmin, R Abdul Cader… - PLoS …, 2021 - journals.plos.org
Introduction IgA nephropathy (IgAN) has a heterogeneous presentation and the progression
to end stage renal disease (ESRD) is often influenced by demographics, ethnicity, as well as …

Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.

R Mohd, MK NE, A Cader, N Abd Shukor, YP Wong… - Plos one, 2021 - europepmc.org
Methods This study included all biopsy-proven IgAN patients with≥ 1year follow-up.
Patients with diabetes mellitus at diagnosis and secondary IgAN were excluded. Medical …

Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.

R Mohd, NEM Kazmin, RA Cader, N Abd Shukor… - PLoS ONE, 2021 - go.gale.com
Introduction IgA nephropathy (IgAN) has a heterogeneous presentation and the progression
to end stage renal disease (ESRD) is often influenced by demographics, ethnicity, as well as …

[PDF][PDF] Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience

R Mohd, NE Mohammad Kazmin… - PLoS …, 2021 - pdfs.semanticscholar.org
IgA nephropathy (IgAN) has a heterogeneous presentation and the progression to end stage
renal disease (ESRD) is often influenced by demographics, ethnicity, as well as choice of …

Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.

R Mohd, NE Mohammad Kazmin… - PLoS …, 2021 - search.ebscohost.com
Abstract Introduction: IgA nephropathy (IgAN) has a heterogeneous presentation and the
progression to end stage renal disease (ESRD) is often influenced by demographics …

[HTML][HTML] Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience

R Mohd, NEM Kazmin, RA Cader, N Abd Shukor… - PLoS ONE, 2021 - ncbi.nlm.nih.gov
Methods This study included all biopsy-proven IgAN patients with≥ 1year follow-up.
Patients with diabetes mellitus at diagnosis and secondary IgAN were excluded. Medical …

[引用][C] Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience

R Mohd, NE Mohammad Kazmin… - PLoS …, 2021 - ui.adsabs.harvard.edu
Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience -
NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS Long term …

[PDF][PDF] Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience

R Mohd, NE Mohammad Kazmin, R Abdul Cader… - PLoS ONE, 2021 - researchgate.net
IgA nephropathy (IgAN) has a heterogeneous presentation and the progression to end stage
renal disease (ESRD) is often influenced by demographics, ethnicity, as well as choice of …

Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience

R Mohd, NEM Kazmin, RA Cader… - PloS …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction IgA nephropathy (IgAN) has a heterogeneous presentation and the progression
to end stage renal disease (ESRD) is often influenced by demographics, ethnicity, as well as …

[PDF][PDF] Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience

R Mohd, NE Mohammad Kazmin, R Abdul Cader… - PLoS ONE, 2021 - scholar.archive.org
IgA nephropathy (IgAN) has a heterogeneous presentation and the progression to end stage
renal disease (ESRD) is often influenced by demographics, ethnicity, as well as choice of …